Electra Private Equity names two non-executive directors
Ms. Wilding has extensive experience in the private equity investment and healthcare sectors.
Having qualified as a chartered accountant with Ernst & Young, she worked in the private equity division of Mercury Asset Management from 1989 to 2001, rising to the position of Managing Director.
Ms. Wilding has served as a non-executive director (including as Chairman) on the boards of a number of companies.
She is currently a non-executive director of Imperial Innovations Group plc and UDG Healthcare plc. She is currently Chairman of the HgCapital Private Equity Valuation Committee, from which she intends to stand down in January 2017.
She was a non-executive director and latterly Chair of Corin plc from 2006 to 2012.
Dr. McAdam will also be appointed as the Senior Independent Director.
Dr. McAdam has extensive experience of senior leadership of global businesses in a wide range of industry sectors gained from his career with ICI and Unilever over more than 30 years and his other Board and advisor appointments.
Dr. McAdam joined Unilever PLC as a management trainee in 1974 and went on to hold a number of senior positions in Birds Eye Walls, Quest and Unichema before joining ICI plc, where he was Chief Executive until 2007.
He is Chairman of Rentokil Initial plc and United Utilities plc and also a Non-Executive Director of Rolls-Royce Group plc.
He was Senior Independent Director of J Sainsbury PLC until July 2016 and a Non-Executive Director of Sara Lee Corp (2008-14) and Severn Trent plc (2000-05). ■
LATEST MOVES FROM United Kingdom
- Mallinckrodt Pharmaceuticals elects David Norton to board
- John Lewis Partnership appoints Laura Wade-Gery as director
- 40% of senior executives to leave Reckitt Benckiser
- Oxford Immunotec Global appoints Stefan Linn as COO
- Terra Firma Capital appoints Jerry Patava to board
More inside POST
How many mistakes you should tolerate Leadership
Total steps into solar energy market Companies